BACCEGA, TANIA
 Distribuzione geografica
Continente #
EU - Europa 160
NA - Nord America 125
AS - Asia 119
SA - Sud America 15
AF - Africa 4
Totale 423
Nazione #
US - Stati Uniti d'America 119
RU - Federazione Russa 102
SG - Singapore 42
CN - Cina 37
HK - Hong Kong 15
IT - Italia 12
VN - Vietnam 11
BR - Brasile 10
DE - Germania 10
FR - Francia 8
SE - Svezia 8
GB - Regno Unito 6
IN - India 5
CA - Canada 4
ES - Italia 4
PL - Polonia 4
LT - Lituania 3
EC - Ecuador 2
IQ - Iraq 2
IR - Iran 2
JP - Giappone 2
MX - Messico 2
ZA - Sudafrica 2
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
CL - Cile 1
ET - Etiopia 1
FI - Finlandia 1
GY - Guiana 1
HR - Croazia 1
ID - Indonesia 1
MY - Malesia 1
TN - Tunisia 1
Totale 423
Città #
Moscow 24
Singapore 23
Dallas 20
Hong Kong 15
Ashburn 13
Beijing 10
New York 10
San Jose 9
Perugia 8
Munich 6
Hefei 5
Lauterbourg 5
Los Angeles 5
Orem 5
Shanghai 5
Houston 4
Warsaw 4
Atlanta 3
Frankfurt am Main 3
Baghdad 2
Boardman 2
Brooklyn 2
Chennai 2
Hanoi 2
Ho Chi Minh City 2
Johannesburg 2
Mexico City 2
New Delhi 2
Seattle 2
Stockholm 2
São Paulo 2
The Dalles 2
Tokyo 2
Toronto 2
Washington 2
Addis Ababa 1
Buffalo 1
Columbus 1
Da Nang 1
Duluth 1
Duque de Caxias 1
Fortaleza 1
Georgetown 1
Goya 1
Guangzhou 1
Guayaquil 1
Hacienda Ibarra 1
Hangzhou 1
Helsinki 1
Hưng Yên 1
Hải Dương 1
Itatiba 1
Jakarta 1
Kirkcaldy 1
Kuala Lumpur 1
Lawrence 1
Louisville 1
Manassas 1
Manchester 1
Milan 1
Montreal 1
Phoenix 1
Ponte Nova 1
Poplar 1
Porto Alegre 1
Princeton 1
Quận Hai 1
Recife 1
Regina 1
Reston 1
Rio Grande 1
Rome 1
Santa Clara 1
Sousse 1
St Louis 1
Taquara 1
Tolentino 1
Vilnius 1
Wuhu 1
Zagreb 1
Totale 254
Nome #
Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I-/- iPSCs for β cell replacement 102
GENE SILENCING 100
Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis 81
Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I-/- iPSC for cell therapy of type 1 diabetes 76
Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I-/- iPSC-derived β cells for cell therapy of type 1 diabetes 75
Totale 434
Categoria #
all - tutte 1.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.700


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221 0 0 0 1 0 0 0 0 0 0 0 0
2022/202310 3 2 0 1 1 2 0 1 0 0 0 0
2023/202415 0 2 3 4 0 2 0 2 0 0 0 2
2024/202591 3 0 9 5 9 8 11 12 12 8 6 8
2025/2026316 20 18 24 47 25 20 26 30 90 16 0 0
Totale 434